Project Details
Description
mafodotin plus rituximab, ifosfamide, carboplatin, and etoposide chemotherapy vs. RICE in the treatment of patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) who are candidates for autologous stem cell transplant
| Status | Finished |
|---|---|
| Effective start/end date | 9/1/15 → 3/30/20 |
Funding
- SEAGEN INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.